Year |
Citation |
Score |
2011 |
Xiang H, Noonan EJ, Wang J, Duan H, Ma LK, Michie S, Boxer LM. The Immunoglobulin Heavy Chain Gene 3’ Enhancers Induce Bcl2 Deregulation and Lymphomagenesis in Murine B Cells Leukemia. 25: 1484-1493. PMID 21606958 DOI: 10.1038/Leu.2011.115 |
0.424 |
|
2008 |
Duan H, Xiang H, Ma L, Boxer LM. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells Oncogene. 27: 6720-6728. PMID 18695675 DOI: 10.1038/Onc.2008.286 |
0.392 |
|
2008 |
Saini HS, Chu AK, Boxer LM, Sato-Bigbee C. Signalling pathways linking proliferation and survival in oligodendrocyte progenitors Journal of Neurochemistry. 81: 46-48. DOI: 10.1046/J.1471-4159.81.S1.15_9.X |
0.501 |
|
2007 |
Dhakshinamoorthy S, Sridharan SR, Li L, Ng PY, Boxer LM, Porter AG. Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. Nucleic Acids Research. 35: 5439-51. PMID 17702766 DOI: 10.1093/Nar/Gkm594 |
0.522 |
|
2007 |
Gao J, Liu YG, Zhou Y, Boxer LM, Woolley FR, Zingaro RA. Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines. Chembiochem : a European Journal of Chemical Biology. 8: 332-40. PMID 17203500 DOI: 10.1002/Cbic.200600299 |
0.409 |
|
2007 |
Duan H, Heckman CA, Boxer LM. The immunoglobulin heavy-chain gene 3′ enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells Oncogene. 26: 2635-2641. PMID 17043638 DOI: 10.1038/Sj.Onc.1210061 |
0.572 |
|
2006 |
Xiang H, Wang J, Boxer LM. Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. Molecular and Cellular Biology. 26: 8599-606. PMID 16982684 DOI: 10.1128/Mcb.01062-06 |
0.547 |
|
2006 |
Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 800-2. PMID 16469847 DOI: 10.1096/Fj.05-5426Fje |
0.506 |
|
2006 |
Heckman CA, Duan H, Garcia PB, Boxer LM. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression Oncogene. 25: 888-898. PMID 16186795 DOI: 10.1038/Sj.Onc.1209127 |
0.57 |
|
2005 |
Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Molecular Cancer Research : McR. 3: 585-96. PMID 16254192 DOI: 10.1158/1541-7786.Mcr-05-0111 |
0.495 |
|
2005 |
Duan H, Heckman CA, Boxer LM. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Molecular and Cellular Biology. 25: 1608-19. PMID 15713621 DOI: 10.1128/Mcb.25.5.1608-1619.2005 |
0.498 |
|
2005 |
Wang J, Boxer LM. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. The Journal of Biological Chemistry. 280: 12766-73. PMID 15687498 DOI: 10.1074/Jbc.M412446200 |
0.504 |
|
2005 |
Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. C/EBPα and C/EBPα Myeloid Oncoproteins Induce Bcl-2 Via Interaction of Their Basic Regions with NF-κB p50. Blood. 106: 2992-2992. DOI: 10.1182/Blood.V106.11.2992.2992 |
0.479 |
|
2005 |
Xiang H, Boxer LM. The Role of the cAMP-Response Element in the Bcl-2 Promoter in the Regulation of Endogenous Bcl-2 Expression and Apoptosis in Murine B Cells. Blood. 106: 2987-2987. DOI: 10.1182/Blood.V106.11.2987.2987 |
0.536 |
|
2005 |
Wang J, Boxer LM. The Role of p53 in C-myc Induced Lymphomagenesis Mediated by the IgH 3′ Enhancers. Blood. 106: 2610-2610. DOI: 10.1182/Blood.V106.11.2610.2610 |
0.507 |
|
2004 |
Saini HS, Gorse KM, Boxer LM, Sato-Bigbee C. Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. Journal of Neurochemistry. 89: 951-61. PMID 15140194 DOI: 10.1111/J.1471-4159.2004.02365.X |
0.536 |
|
2004 |
Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood. 103: 1043-9. PMID 14525776 DOI: 10.1182/Blood-2003-05-1518 |
0.369 |
|
2004 |
Paz-Priel I, Cai DH, Wang D, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD. C/EBPα and C/EBPα Myeloid Oncoproteins Inhibit Apoptosis and Induce Bcl-2 Via DNA-Binding Dependent and Independent Mechanisms. Blood. 104: 2561-2561. DOI: 10.1182/Blood.V104.11.2561.2561 |
0.521 |
|
2004 |
Kanda K, Wong W, Boxer LM. Enhanced Apoptosis to Chemotherapeutic Agents Is Dependent on NFκB and Bcl2-Related Proteins but Is Independent of P53 and Bax in Burkitt’s Lymphoma Cells. Blood. 104: 1541-1541. DOI: 10.1182/Blood.V104.11.1541.1541 |
0.508 |
|
2004 |
Duan H, Heckman CA, Boxer LM. HDAC2 Plays a Role in Protecting t(14;18) Lymphoma Cells from Apoptosis by Up-Regulation of Bcl-2. Blood. 104: 1133-1133. DOI: 10.1182/Blood.V104.11.1133.1133 |
0.486 |
|
2003 |
Heckman CA, Cao T, Somsouk L, Duan H, Mehew JW, Zhang CY, Boxer LM. Critical Elements of the Immunoglobulin Heavy Chain Gene Enhancers for Deregulated Expression of Bcl-2 Cancer Research. 63: 6666-6673. PMID 14583460 |
0.45 |
|
2003 |
Heckman CA, Wheeler MA, Boxer LM. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. Oncogene. 22: 7891-9. PMID 12970736 DOI: 10.1038/Sj.Onc.1206639 |
0.55 |
|
2003 |
Jambal P, Masterson S, Nesterova A, Bouchard R, Bergman B, Hutton JC, Boxer LM, Reusch JE, Pugazhenthi S. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. The Journal of Biological Chemistry. 278: 23055-65. PMID 12679364 DOI: 10.1074/Jbc.M212450200 |
0.502 |
|
2003 |
Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, Eves E, Rosner MR, Boxer LM, Reusch JE. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. Journal of Neurochemistry. 84: 982-96. PMID 12603823 DOI: 10.1046/J.1471-4159.2003.01606.X |
0.435 |
|
2002 |
Zhang CY, Wu YL, Boxer LM. Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells. The Journal of Biological Chemistry. 277: 48359-65. PMID 12374787 DOI: 10.1074/Jbc.M209329200 |
0.502 |
|
2002 |
Heckman CA, Boxer LM. Allele-specific analysis of transcription factors binding to promoter regions Methods. 26: 19-26. PMID 12054901 DOI: 10.1016/S1046-2023(02)00004-X |
0.45 |
|
2002 |
Heckman CA, Mehew JW, Boxer LM. NF-κb activates Bcl-2 expression in t(14;18) lymphoma cells Oncogene. 21: 3898-3908. PMID 12032828 DOI: 10.1038/Sj.Onc.1205483 |
0.536 |
|
2002 |
Hu HM, Arcinas M, Boxer LM. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma. The Journal of Biological Chemistry. 277: 9819-24. PMID 11777933 DOI: 10.1074/Jbc.M111426200 |
0.525 |
|
2001 |
Li C, Ahlborn TE, Tokita K, Boxer LM, Noda A, Liu J. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Oncogene. 20: 8193-8202. PMID 11781835 DOI: 10.1038/Sj.Onc.1205046 |
0.356 |
|
2001 |
Boxer LM, Dang CV. Translocations involving c-myc and c-myc function Oncogene. 20: 5595-5610. PMID 11607812 DOI: 10.1038/Sj.Onc.1204595 |
0.453 |
|
2001 |
Freeland K, Boxer LM, Latchman DS. The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells Molecular Brain Research. 92: 98-106. PMID 11483246 DOI: 10.1016/S0169-328X(01)00158-9 |
0.482 |
|
2001 |
Sinha S, Jancarik J, Roginskaya V, Rothermund K, Boxer LM, Corey SJ. Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl. Experimental Hematology. 29: 746-55. PMID 11378270 DOI: 10.1016/S0301-472X(01)00647-6 |
0.418 |
|
2001 |
Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene. 20: 240-251. PMID 11313951 DOI: 10.1038/Sj.Onc.1204067 |
0.478 |
|
2000 |
Groot M, Boxer LM, Thiel G. Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. European Journal of Cell Biology. 79: 924-935. PMID 11152283 DOI: 10.1078/0171-9335-00126 |
0.478 |
|
2000 |
Kanda K, Hu H, Zhang L, Grandchamps J, Boxer LM. NF-κB Activity Is Required for the Deregulation of c-mycExpression by the Immunoglobulin Heavy Chain Enhancer Journal of Biological Chemistry. 275: 32338-32346. PMID 10931834 DOI: 10.1074/Jbc.M004148200 |
0.527 |
|
2000 |
Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. The Journal of Biological Chemistry. 275: 10761-6. PMID 10753867 DOI: 10.1074/Jbc.275.15.10761 |
0.459 |
|
2000 |
Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM. A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells Journal of Biological Chemistry. 275: 6499-6508. PMID 10692454 DOI: 10.1074/Jbc.275.9.6499 |
0.574 |
|
1999 |
Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, Reusch JEB. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein Journal of Biological Chemistry. 274: 27529-27535. PMID 10488088 DOI: 10.1074/Jbc.274.39.27529 |
0.491 |
|
1999 |
Chalaux E, López-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F. A zinc-finger transcription factor induced by TGF-β promotes apoptotic cell death in epithelial Mv1Lu cells Febs Letters. 457: 478-482. PMID 10471833 DOI: 10.1016/S0014-5793(99)01051-0 |
0.393 |
|
1999 |
Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. The Journal of Biological Chemistry. 274: 15237-44. PMID 10329733 DOI: 10.1074/Jbc.274.21.15237 |
0.425 |
|
1999 |
Liu YZ, Boxer LM, Latchman DS. Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Research. 27: 2086-90. PMID 10219080 DOI: 10.1093/Nar/27.10.2086 |
0.413 |
|
1998 |
Smith MD, Dawson SJ, Boxer LM, Latchman DS. The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bbcl-2 gene expression. Nucleic Acids Research. 26: 4100-7. PMID 9722627 DOI: 10.1093/Nar/26.18.4100 |
0.422 |
|
1998 |
Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. The Journal of Biological Chemistry. 273: 16715-22. PMID 9642226 DOI: 10.1074/Jbc.273.27.16715 |
0.472 |
|
1997 |
Heckman C, Mochon E, Arcinas M, Boxer LM. The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t(14;18) Lymphomas Journal of Biological Chemistry. 272: 19609-19614. PMID 9235968 DOI: 10.1074/Jbc.272.31.19609 |
0.482 |
|
1997 |
Sullivan J, Feeley B, Guerra J, Boxer LM. Identification of the Major Positive Regulators of c-myb Expression in Hematopoietic Cells of Different Lineages Journal of Biological Chemistry. 272: 1943-1949. PMID 8999884 DOI: 10.1074/Jbc.272.3.1943 |
0.53 |
|
1996 |
Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Molecular and Cellular Biology. 16: 5546-56. PMID 8816467 DOI: 10.1128/Mcb.16.10.5546 |
0.565 |
|
1996 |
Ji L, Mochon E, Arcinas M, Boxer LM. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. The Journal of Biological Chemistry. 271: 22687-91. PMID 8798441 DOI: 10.1074/Jbc.271.37.22687 |
0.495 |
|
1996 |
Phan S, Feeley B, Withers D, Boxer LM. Identification of an inducible regulator of c-myb expression during T-cell activation. Molecular and Cellular Biology. 16: 2387-2393. PMID 8628306 DOI: 10.1128/Mcb.16.5.2387 |
0.501 |
|
1995 |
Chen HM, Boxer LM. π1 Binding sites are negative regulators of bcl-2 expression in pre-B cells Molecular and Cellular Biology. 15: 3840-3847. PMID 7791791 DOI: 10.1128/Mcb.15.7.3840 |
0.523 |
|
1995 |
Ji L, Arcinas M, Boxer LM. The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma. The Journal of Biological Chemistry. 270: 13392-8. PMID 7768941 DOI: 10.1074/Jbc.270.22.13392 |
0.492 |
|
1995 |
McCann S, Sullivan J, Guerra J, Arcinas M, Boxer LM. Repression of the c-myb Gene by WT1 Protein in T and B Cell Lines Journal of Biological Chemistry. 270: 23785-23789. PMID 7559553 DOI: 10.1074/Jbc.270.40.23785 |
0.546 |
|
1995 |
Guerra J, Withers D, Boxer L. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines. Blood. 86: 1873-1880. DOI: 10.1182/Blood.V86.5.1873.Bloodjournal8651873 |
0.518 |
|
1994 |
Boxer LM. The Role of Oncogenes in Hematologic Malignancies Annual Review of Medicine. 45: 1-11. PMID 8198369 DOI: 10.1146/Annurev.Med.45.1.1 |
0.373 |
|
1989 |
Boxer LM, Prywes R, Roeder RG, Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Molecular and Cellular Biology. 9: 515-22. PMID 2710114 DOI: 10.1128/mcb.9.2.515-522.1989 |
0.422 |
|
1988 |
Gustafson TA, Miwa T, Boxer LM, Kedes L. Interaction of nuclear proteins with muscle-specific regulation sequences of the human cardiac α-actin promoter Molecular and Cellular Biology. 8: 4110-4119. PMID 3185542 DOI: 10.1128/Mcb.8.10.4110 |
0.464 |
|
Show low-probability matches. |